Archive for October, 2004

h1

109908285293296827

October 29, 2004

Financial Snapshot For September 2004
In need of a boost.

Advertisements
h1

109898799986889078

October 28, 2004

Biotech: The “safe” drug bet?
“Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”

h1

109874119453756407

October 25, 2004

Biotech execs have a sense of humor about elusive profits
When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.

h1

109856128463932864

October 23, 2004

Is That a Pilot in Your Pocket?
“Somewhere in Florida, 25,000 disembodied rat neurons are thinking about flying an F-22. “

h1

109822895645610513

October 19, 2004

Foresight or folly? Generics firms’ foray into NCEs
A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into new territory?

h1

109814479590607417

October 18, 2004

How many trillions for a drug miracle?
“Here’s a quick thought experiment about the current system for developing and paying for miracle drugs: Would it be worth almost any price to develop a drug with a better than 50-50 probability of conquering many of the world’s most deadly diseases? “

h1

109787075409196548

October 15, 2004

State biotech sector no miracle drug for creation of jobs
“Ruth Scott’s job is to be the No. 1 cheerleader for biotechnology in Washington state. But when politicians talk up the industry as a silver bullet for job growth, she cringes.”